Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn’s Disease Patients Already on Every-4-Week Dosing
Rocío Sedaño, Leonardo Guizzetti, Cassandra McDonald, Vipul Jairath
Topics & Concepts
UstekinumabMedicineCrohn's diseaseInternal medicineGastroenterologyVedolizumabMaintenance therapyDiseaseInfliximabChemotherapyInflammatory Bowel DiseaseImmunodeficiency and Autoimmune DisordersEosinophilic Esophagitis